STOCK TITAN

[Form 4] Lumentum Holdings Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.

No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.

Lumentum (NASDAQ:LITE) ha presentato un Modulo 4 che rivela che il direttore Alan S. Lowe ha venduto 20.000 azioni ordinarie il 26/06/2025 a $93,47, generando circa 1,87 milioni di dollari. L'operazione, eseguita nell'ambito di un piano Rule 10b5-1 adottato il 20/11/2024, ha ridotto la sua partecipazione diretta di circa l'8%, portandola a 230.471 azioni.

Non sono state segnalate transazioni derivate. Sebbene programmata in anticipo, la dimensione della vendita supera le soglie di rilevanza e potrebbe influenzare il sentiment degli investitori.

Lumentum (NASDAQ:LITE) presentó un Formulario 4 que revela que el director Alan S. Lowe vendió 20,000 acciones comunes el 26/06/2025 a $93.47, generando aproximadamente $1.87 millones. La operación, ejecutada bajo un plan Rule 10b5-1 adoptado el 20/11/2024, redujo su participación directa en alrededor del 8%, quedando en 230,471 acciones.

No se reportaron transacciones derivadas. Aunque fue una venta programada, el tamaño de la operación supera los umbrales de materialidad y podría influir en el sentimiento de los inversores.

Lumentum (NASDAQ:LITE)은(는) 이사 Alan S. Lowe가 2025년 6월 26일에 20,000주 보통주를 주당 $93.47에 매도하여 약 187만 달러를 창출했다고 신고한 Form 4를 제출했습니다. 이 거래는 2024년 11월 20일에 채택된 Rule 10b5-1 계획에 따라 실행되었으며, 그의 직접 지분을 약 8% 감소시켜 230,471주가 되었습니다.

파생상품 거래는 보고되지 않았습니다. 사전에 계획된 거래이지만, 매도 규모가 중요성 기준을 초과하여 투자자 심리에 영향을 미칠 수 있습니다.

Lumentum (NASDAQ:LITE) a déposé un formulaire 4 révélant que le directeur Alan S. Lowe a vendu 20 000 actions ordinaires le 26/06/2025 au prix de 93,47 $, générant environ 1,87 million de dollars. La transaction, réalisée dans le cadre d’un plan Rule 10b5-1 adopté le 20/11/2024, a réduit sa participation directe d’environ 8 %, la portant à 230 471 actions.

Aucune transaction dérivée n’a été signalée. Bien que la vente ait été programmée à l’avance, son volume dépasse les seuils de matérialité et pourrait influencer le sentiment des investisseurs.

Lumentum (NASDAQ:LITE) reichte ein Formular 4 ein, das offenlegt, dass Direktor Alan S. Lowe am 26.06.2025 20.000 Stammaktien zu je $93,47 verkauft hat und dabei rund 1,87 Millionen Dollar einnahm. Der Handel wurde im Rahmen eines am 20.11.2024 eingeführten Rule 10b5-1 Plans durchgeführt und verringerte seinen direkten Anteil um etwa 8 % auf 230.471 Aktien.

Es wurden keine Derivatgeschäfte gemeldet. Obwohl der Verkauf vorab geplant war, überschreitet das Volumen die Wesentlichkeitsschwellen und könnte die Anlegerstimmung beeinflussen.

Positive
  • None.
Negative
  • Director Alan S. Lowe sold 20,000 shares (~8% of his holdings) for approximately $1.87 million, potentially signaling cautious sentiment despite 10b5-1 scheduling.

Insights

Director's $1.87 M 10b5-1 sale trims stake 8%; signal modest, watch earnings for confirmation.

The 20,000-share disposition equals ~8% of Lowe’s holdings and crosses the $1 M significance bar. Because the sale is governed by a pre-arranged Rule 10b5-1 plan, informational content is muted versus discretionary selling. Still, a nearly $2 M cash-out can pressure short-term sentiment in a momentum-sensitive optical components sector. Lowe retains 230,471 shares, suggesting continued alignment. Absent other insiders joining in or soft near-term guidance, I view the transaction as a neutral data point rather than a forward indicator of deteriorating fundamentals.

Material insider sale disclosed under enhanced 10b5-1 rules; optics mildly negative.

The filing satisfies the SEC’s updated 10b5-1 disclosure checkboxes, supporting procedural integrity. However, a near-$2 M sale by a sitting director can attract scrutiny from proxy advisers, especially if accompanied by equity award refreshes or lagging TSR. Lowe’s remaining 230k-share stake still aligns his interests with shareholders, tempering concern. From a governance standpoint the transaction is properly transparent, yet the sheer size may weigh on perception until new performance data arrive.

Lumentum (NASDAQ:LITE) ha presentato un Modulo 4 che rivela che il direttore Alan S. Lowe ha venduto 20.000 azioni ordinarie il 26/06/2025 a $93,47, generando circa 1,87 milioni di dollari. L'operazione, eseguita nell'ambito di un piano Rule 10b5-1 adottato il 20/11/2024, ha ridotto la sua partecipazione diretta di circa l'8%, portandola a 230.471 azioni.

Non sono state segnalate transazioni derivate. Sebbene programmata in anticipo, la dimensione della vendita supera le soglie di rilevanza e potrebbe influenzare il sentiment degli investitori.

Lumentum (NASDAQ:LITE) presentó un Formulario 4 que revela que el director Alan S. Lowe vendió 20,000 acciones comunes el 26/06/2025 a $93.47, generando aproximadamente $1.87 millones. La operación, ejecutada bajo un plan Rule 10b5-1 adoptado el 20/11/2024, redujo su participación directa en alrededor del 8%, quedando en 230,471 acciones.

No se reportaron transacciones derivadas. Aunque fue una venta programada, el tamaño de la operación supera los umbrales de materialidad y podría influir en el sentimiento de los inversores.

Lumentum (NASDAQ:LITE)은(는) 이사 Alan S. Lowe가 2025년 6월 26일에 20,000주 보통주를 주당 $93.47에 매도하여 약 187만 달러를 창출했다고 신고한 Form 4를 제출했습니다. 이 거래는 2024년 11월 20일에 채택된 Rule 10b5-1 계획에 따라 실행되었으며, 그의 직접 지분을 약 8% 감소시켜 230,471주가 되었습니다.

파생상품 거래는 보고되지 않았습니다. 사전에 계획된 거래이지만, 매도 규모가 중요성 기준을 초과하여 투자자 심리에 영향을 미칠 수 있습니다.

Lumentum (NASDAQ:LITE) a déposé un formulaire 4 révélant que le directeur Alan S. Lowe a vendu 20 000 actions ordinaires le 26/06/2025 au prix de 93,47 $, générant environ 1,87 million de dollars. La transaction, réalisée dans le cadre d’un plan Rule 10b5-1 adopté le 20/11/2024, a réduit sa participation directe d’environ 8 %, la portant à 230 471 actions.

Aucune transaction dérivée n’a été signalée. Bien que la vente ait été programmée à l’avance, son volume dépasse les seuils de matérialité et pourrait influencer le sentiment des investisseurs.

Lumentum (NASDAQ:LITE) reichte ein Formular 4 ein, das offenlegt, dass Direktor Alan S. Lowe am 26.06.2025 20.000 Stammaktien zu je $93,47 verkauft hat und dabei rund 1,87 Millionen Dollar einnahm. Der Handel wurde im Rahmen eines am 20.11.2024 eingeführten Rule 10b5-1 Plans durchgeführt und verringerte seinen direkten Anteil um etwa 8 % auf 230.471 Aktien.

Es wurden keine Derivatgeschäfte gemeldet. Obwohl der Verkauf vorab geplant war, überschreitet das Volumen die Wesentlichkeitsschwellen und könnte die Anlegerstimmung beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LOWE ALAN S

(Last) (First) (Middle)
C/O LUMENTUM HOLDINGS INC.
1001 RIDDER PARK DRIVE

(Street)
SAN JOSE CA 95131

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lumentum Holdings Inc. [ LITE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 S(1) 20,000 D $93.47 230,471 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.
/s/ Jae Kim as Attorney-in-Fact 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many LITE shares did director Alan S. Lowe sell on 06/26/2025?

He sold 20,000 shares according to the Form 4.

What was the average sale price of the shares sold by Lowe?

The reported average price was $93.47 per share.

What was the total dollar value of Lowe's sale?

The transaction totaled roughly $1.87 million (20,000 × $93.47).

What percentage of Lowe's LITE holdings was sold?

About 8% of his pre-sale 250,471-share position.

How many LITE shares does Lowe still own after the sale?

He continues to hold 230,471 shares directly.

Was the sale executed under a Rule 10b5-1 trading plan?

Yes, the shares were sold under a Rule 10b5-1 plan adopted on 11/20/2024.
Lumentum Hldgs Inc

NASDAQ:LITE

LITE Rankings

LITE Latest News

LITE Latest SEC Filings

LITE Stock Data

6.19B
68.82M
0.89%
117.64%
14.94%
Communication Equipment
Communications Equipment, Nec
Link
United States
SAN JOSE